Advanced Proteome Therapeutics Corporation
APTCF · OTC
7/31/2022 | 7/31/2021 | 7/31/2020 | 7/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1 | $0 | $0 | $1 |
| G&A Expenses | $0 | $0 | $1 | $1 |
| SG&A Expenses | $0 | $0 | $1 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2 | -$1 | $0 | $0 |
| Pre-Tax Income | $1 | -$2 | -$1 | -$0 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | $1 | -$2 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS | 0.019 | -0.059 | -0.02 | -0.019 |
| % Growth | 132.7% | -190.6% | -5.2% | – |
| EPS Diluted | 0.019 | -0.059 | -0.02 | -0.019 |
| Weighted Avg Shares Out | 39 | 32 | 22 | 17 |
| Weighted Avg Shares Out Dil | 39 | 32 | 22 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | – |